CHS Moves Away From Isoflavones, Sells Solgen

635634801296576746soy heart.jpg

01 Apr 2015 --- Just three years after purchasing the Israeli soy protein firm, CHS, North America’s leading farmer-owned cooperative and a global energy, grains and foods company, announced it has sold Solgen isoflavone brand and related business to Tradichem S.L., Madrid, Spain.

Tradichem’s core business is the development and supply of pharmaceutical and nutraceutical ingredients. The transaction includes all CHS isoflavone inventory, the Solgen brand name and customer list, technology related to the product and the Solgen European Drug Master File.

“CHS recently ceased production of food-grade soy ingredients at its Ashdod, Israel, plant, and will no longer manufacture isoflavones,” said Tom Malecha, CHS vice president, Processing and Food Ingredients. “In addition to acquiring the Solgen inventory and related business assets, Tradichem will also assume all liabilities related to the former CHS isoflavone manufacturing, supply and distribution.”

Jose Angel Marañón, PhD., Tradichem executive director and director of research and development, said that Tradichem has been the CHS distributor of Solgen products for many years; making it a good fit within Tradichem’s portfolio. “We are proud to own the Solgen technology, inventory and brand and look forward to continuing to represent this outstanding product within our business,” said Marañón. 

Tradichem holds exclusive distribution agreements with global pharmaceutical and nutraceutical companies based in Israel, Germany, Switzerland and the US. Tradichem has built a culture of innovation to maximize the business growth, which is driven by initiatives underway at the Tradichem Innovation Center (TIC) laboratory, a research center hosted by Parque Científico de Madrid (PCM). 

Related Articles

Business News

Lonza to expand Florida encapsulation capabilities amid product development acceleration

21 Feb 2018 --- Swiss multinational, chemicals and biotechnology company, the Lonza Group is planning to expand its late-stage clinical and commercial encapsulation capabilities for solid oral and inhaled dosage forms in North America. The company will install a new Harro Hӧfliger Modu-C MS encapsulation unit (Harro unit) at its integrated product development and manufacturing facility in Tampa, Florida, to strengthen production and bring its products to market faster. 

Nutrition & Health News

Low-carb diet found to help battle fatty liver disease

20 Feb 2018 --- A carbohydrate-restricted diet can lead to “rapid and dramatic” reductions of liver fat and other cardiometabolic risk factors, along with marked decreases in the synthesis of hepatic fat, reveals a study published last week in Cell Metabolism. The study results could lead to improved treatments for non-alcoholic fatty liver disease (NAFLD). 

Nutrition & Health News

Yogurt may reduce cardiovascular disease risk

19 Feb 2018 --- A higher yogurt intake is associated with lower cardiovascular disease risk among hypertensive men and women, a study in the American Journal of Hypertension suggests. High blood pressure is a major cardiovascular disease risk factor. Clinical trials have previously demonstrated beneficial effects of dairy consumption on cardiovascular health, and yogurt may independently be related to cardiovascular disease risk.

Nutrition & Health News

Drink your vitamins: SternVitamin launches micronutrient premix for beverages 

19 Feb 2018 --- A healthy lifestyle is essential to all age groups, and nutrition plays a major role alongside various other components. SternVitamin is now offering beverage manufacturers a novel way to address the topic of health with a new micronutrient premix for healthy bones and heart. SternVitamin notes that the mix picks up on one of the top trends in the beverage market – water-based enriched products. The vegan premix contains vitamins B1, B12, C, K2 and D3. Organic agave syrup powder gives it a slight sweetness, while natural flavors give the drink a “dark berry” taste. It dissolves clear in water and leaves no turbidity. 

Nutrition & Health News

“Unhelpful”: EU regulatory framework fuels nutrition industry dissatisfaction 

16 Feb 2018 --- A survey reveals that one-third of all nutrition industry professionals believe that the current EU framework for achieving a health claim on new products is stunting innovation because it’s complicated, expensive, long-winded and has several “gray areas.” And “regulation frustration” is a strong feeling running through the industry with many more professionals now believing the current EU regulatory environment is “unhelpful” – a 25 percent hike compared with statistics from the beginning of 2017. Experts are attributing this sharp rise in dissatisfaction to the EU’s tough stance on health claims and the current regulatory deadlock on botanicals.

More Articles
URL : http://www.nutritioninsight.com:80/news/CHS-Moves-Away-From-Isoflavones-Sells-Solgen.html